These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 16059652
1. Epidermal growth factor receptor--its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas. Mrhalova M, Plzak J, Betka J, Kodet R. Neoplasma; 2005; 52(4):338-43. PubMed ID: 16059652 [Abstract] [Full Text] [Related]
2. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy BA, Netterville J, Burkey BB, Sinard R, Cmelak A, Levy S, Yarbrough WG, Slebos RJ, Hirsch FR. J Clin Oncol; 2006 Sep 01; 24(25):4170-6. PubMed ID: 16943533 [Abstract] [Full Text] [Related]
3. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. Temam S, Kawaguchi H, El-Naggar AK, Jelinek J, Tang H, Liu DD, Lang W, Issa JP, Lee JJ, Mao L. J Clin Oncol; 2007 Jun 01; 25(16):2164-70. PubMed ID: 17538160 [Abstract] [Full Text] [Related]
4. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma. Buckley AF, Burgart LJ, Kakar S. Hum Pathol; 2006 Apr 01; 37(4):410-4. PubMed ID: 16564914 [Abstract] [Full Text] [Related]
5. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. Hirsch FR, Varella-Garcia M, Bunn PA, Di Maria MV, Veve R, Bremmes RM, Barón AE, Zeng C, Franklin WA. J Clin Oncol; 2003 Oct 15; 21(20):3798-807. PubMed ID: 12953099 [Abstract] [Full Text] [Related]
6. EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas. Nakata Y, Uzawa N, Takahashi K, Sumino J, Michikawa C, Sato H, Sonoda I, Ohyama Y, Okada N, Amagasa T. Eur J Cancer; 2011 Oct 15; 47(15):2364-72. PubMed ID: 21852109 [Abstract] [Full Text] [Related]
7. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas. Yang YL, Xu KL, Zhou Y, Gao X, Chen LR. Chin Med J (Engl); 2012 Feb 15; 125(3):450-4. PubMed ID: 22490401 [Abstract] [Full Text] [Related]
8. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study. Lee HJ, Xu X, Choe G, Chung DH, Seo JW, Lee JH, Lee CT, Jheon S, Sung SW, Chung JH. Lung Cancer; 2010 Jun 15; 68(3):375-82. PubMed ID: 19712993 [Abstract] [Full Text] [Related]
9. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Sok JC, Coppelli FM, Thomas SM, Lango MN, Xi S, Hunt JL, Freilino ML, Graner MW, Wikstrand CJ, Bigner DD, Gooding WE, Furnari FB, Grandis JR. Clin Cancer Res; 2006 Sep 01; 12(17):5064-73. PubMed ID: 16951222 [Abstract] [Full Text] [Related]
10. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression. Willmore-Payne C, Holden JA, Layfield LJ. Hum Pathol; 2006 Jun 01; 37(6):755-63. PubMed ID: 16733218 [Abstract] [Full Text] [Related]
11. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma. Young RJ, Rischin D, Fisher R, McArthur GA, Fox SB, Peters LJ, Corry J, Lim A, Waldeck K, Solomon B. Cancer Epidemiol Biomarkers Prev; 2011 Jun 01; 20(6):1230-7. PubMed ID: 21467228 [Abstract] [Full Text] [Related]
12. Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells. Erjala K, Sundvall M, Junttila TT, Zhang N, Savisalo M, Mali P, Kulmala J, Pulkkinen J, Grenman R, Elenius K. Clin Cancer Res; 2006 Jul 01; 12(13):4103-11. PubMed ID: 16818711 [Abstract] [Full Text] [Related]
13. Cetuximab shows activity in colorectal cancer patients with tumors for which FISH analysis does not detect an increase in EGFR gene copy number. Italiano A, Follana P, Caroli FX, Badetti JL, Benchimol D, Garnier G, Gugenheim J, Haudebourg J, Keslair F, Lesbats G, Lledo G, Roussel JF, Pedeutour F, François E. Ann Surg Oncol; 2008 Feb 01; 15(2):649-54. PubMed ID: 17987340 [Abstract] [Full Text] [Related]
14. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study. Suzuki S, Dobashi Y, Sakurai H, Nishikawa K, Hanawa M, Ooi A. Cancer; 2005 Mar 15; 103(6):1265-73. PubMed ID: 15712203 [Abstract] [Full Text] [Related]
15. Protein expression and gene amplification of epidermal growth factor receptor in thymomas. Ionescu DN, Sasatomi E, Cieply K, Nola M, Dacic S. Cancer; 2005 Feb 01; 103(3):630-6. PubMed ID: 15630697 [Abstract] [Full Text] [Related]